MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab

BACKGROUND: Targeted therapies directed at commonly overexpressed pathways in melanoma have clinical activity in numerous trials. Little is known about how these therapies influence microRNA (miRNA) expression, particularly with combination regimens. Knowledge of miRNAs altered with treatment may co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wagenseller, Aubrey G, Shada, Amber, D’Auria, Kevin M, Murphy, Cheryl, Sun, Dandan, Molhoek, Kerrington R, Papin, Jason A, Dutta, Anindya, Slingluff Jr, Craig L
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853033/
https://ncbi.nlm.nih.gov/pubmed/24047116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-218
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars